Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.06
-0.01 (-0.20%)
At close: Jan 13, 2026, 4:00 PM EST
4.900
-0.160 (-3.16%)
After-hours: Jan 13, 2026, 5:33 PM EST
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $321.33 million as of January 13, 2026. Its market cap has decreased by -21.84% in one year.
Market Cap
321.33M
Enterprise Value
177.21M
1-Year Change
-21.84%
Ranking
Category
Stock Price
$5.06
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $321.33M, a decrease of -19.21%. That is a compound annual growth rate of -4.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 321.96M | -6.97% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.49B |
| Johnson & Johnson | 514.75B |
| AbbVie | 390.15B |
| UnitedHealth Group | 302.49B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.70B |
| Novo Nordisk | 265.30B |